Chief Scientific Innovations Officer, The Emmes Company
Marian Ewell, ScD, joined Emmes in 1994 after completing a post-doctoral fellowship at Harvard University. As a graduate student, she developed growth curve models to quantify the effects of environmental exposures on the lung function of children enrolled in the Six Cities Study. As a post-doctoral fellow, she served as the statistician for the Melanoma Committee of the Eastern Cooperative Oncology group and conducted research in survival analysis.
Since joining Emmes, Dr. Ewell has continued to develop expertise in the design and analysis of observational epidemiological studies and multi-center clinical trials, with a focus on studies of clinical and immunological response in fields such as infectious diseases and transplantation. As Chief Scientific Innovations Officer, she is a member of the executive team and takes an active role in the leadership of the company, proactively working toward ensuring the scientific and financial integrity of Emmes. She is responsible for leading a staff of 100 Biostatistics, Bioinformatics and CDISC Services staff, for evaluating and implementing new and existing statistical methodologies within Emmes’ research projects, and for forward-thinking strategic planning and fostering a culture of innovation throughout Emmes.
Dr. Ewell currently serves as the Principal Investigator (PI) of the Statistical and Data Coordinating Center for the NIH/DMID-sponsored Clinical Research in Infectious Diseases contract. Formerly, Dr. Ewell was the Principal Investigator for the Coordinating Center for the following NIH-sponsored research programs: the Clinical Trial of Topical Thalidomide for Aphthous Stomatitis in Patients with HIV/AIDS, the Immune Tolerance Network, the Cooperative Clinical Trials in Transplantation, and the Trial of Calcium for Preeclampsia Prevention. Dr. Ewell reviews grant applications for several NIH agencies and served two terms as the Chair of the Advisory Board for the George Mason Department of Statistics.